Cerundolo V - Search Results

1

Impacts of combining anti-PD-L1 immunotherapy and radiotherapy on the tumour immune microenvironment in a murine prostate cancer model.

Philippou Y, Sjoberg HT, Murphy E, Alyacoubi S, Jones KI, Gordon-Weeks AN, Phyu S, Parkes EE, Gillies McKenna W, Lamb AD, Gileadi U, Cerundolo V, Scheiblin DA, Lockett SJ, Wink DA, Mills IG, Hamdy FC, Muschel RJ, Bryant RJ. Philippou Y, et al. Among authors: cerundolo v. Br J Cancer. 2020 Sep;123(7):1089-1100. doi: 10.1038/s41416-020-0956-x. Epub 2020 Jul 9. Br J Cancer. 2020. PMID: 32641865 Free PMC article.

2

IFN-gamma exposes a cryptic cytotoxic T lymphocyte epitope in HIV-1 reverse transcriptase.

Sewell AK, Price DA, Teisserenc H, Booth BL Jr, Gileadi U, Flavin FM, Trowsdale J, Phillips RE, Cerundolo V. Sewell AK, et al. Among authors: cerundolo v. J Immunol. 1999 Jun 15;162(12):7075-9. J Immunol. 1999. PMID: 10358150

3

Effect of epitope flanking residues on the presentation of N-terminal cytotoxic T lymphocyte epitopes.

Gileadi U, Gallimore A, Van der Bruggen P, Cerundolo V. Gileadi U, et al. Among authors: cerundolo v. Eur J Immunol. 1999 Jul;29(7):2213-22. doi: 10.1002/(SICI)1521-4141(199907)29:07<2213::AID-IMMU2213>3.0.CO;2-8. Eur J Immunol. 1999. PMID: 10427984 Free article.

4

Sensitization of tumour cells to lysis by virus-specific CTL using antibody-targeted MHC class I/peptide complexes.

Ogg GS, Dunbar PR, Cerundolo V, McMichael AJ, Lemoine NR, Savage P. Ogg GS, et al. Among authors: cerundolo v. Br J Cancer. 2000 Mar;82(5):1058-62. doi: 10.1054/bjoc.1999.1042. Br J Cancer. 2000. PMID: 10737389 Free PMC article.

5

Immunotherapy of colorectal cancer.

Smith CL, Dulphy N, Salio M, Cerundolo V. Smith CL, et al. Among authors: cerundolo v. Br Med Bull. 2002;64:181-200. doi: 10.1093/bmb/64.1.181. Br Med Bull. 2002. PMID: 12421733 Review.

6

Depletion of CD25+ regulatory cells results in suppression of melanoma growth and induction of autoreactivity in mice.

Jones E, Dahm-Vicker M, Simon AK, Green A, Powrie F, Cerundolo V, Gallimore A. Jones E, et al. Among authors: cerundolo v. Cancer Immun. 2002 Feb 22;2:1. Cancer Immun. 2002. PMID: 12747746

7

NKT cells enhance CD4+ and CD8+ T cell responses to soluble antigen in vivo through direct interaction with dendritic cells.

Hermans IF, Silk JD, Gileadi U, Salio M, Mathew B, Ritter G, Schmidt R, Harris AL, Old L, Cerundolo V. Hermans IF, et al. Among authors: cerundolo v. J Immunol. 2003 Nov 15;171(10):5140-7. doi: 10.4049/jimmunol.171.10.5140. J Immunol. 2003. PMID: 14607913

8

Synergistic effect of metronomic dosing of cyclophosphamide combined with specific antitumor immunotherapy in a murine melanoma model.

Hermans IF, Chong TW, Palmowski MJ, Harris AL, Cerundolo V. Hermans IF, et al. Among authors: cerundolo v. Cancer Res. 2003 Dec 1;63(23):8408-13. Cancer Res. 2003. PMID: 14679003

9

The VITAL assay: a versatile fluorometric technique for assessing CTL- and NKT-mediated cytotoxicity against multiple targets in vitro and in vivo.

Hermans IF, Silk JD, Yang J, Palmowski MJ, Gileadi U, McCarthy C, Salio M, Ronchese F, Cerundolo V. Hermans IF, et al. Among authors: cerundolo v. J Immunol Methods. 2004 Feb 1;285(1):25-40. doi: 10.1016/j.jim.2003.10.017. J Immunol Methods. 2004. PMID: 14871532

10

Utilizing the adjuvant properties of CD1d-dependent NK T cells in T cell-mediated immunotherapy.

Silk JD, Hermans IF, Gileadi U, Chong TW, Shepherd D, Salio M, Mathew B, Schmidt RR, Lunt SJ, Williams KJ, Stratford IJ, Harris AL, Cerundolo V. Silk JD, et al. Among authors: cerundolo v. J Clin Invest. 2004 Dec;114(12):1800-11. doi: 10.1172/JCI22046. J Clin Invest. 2004. PMID: 15599405 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

320 results

Search Page